[en] Background: Cysteinyl-leukotrienes are lipid derived mediators involved in asthma. They are able to stimulate eosinophil chemotaxis in vitro. Induced sputum from asthmatics has been shown to contain eosinophil chemotactic activity. The purpose of our study was to evaluate the contribution of cysteinyl-leukotrienes to sputum eosinophil chemotactic activity in asthmatics and to seek whether there might be differences between asthmatics free of inhaled corticosteroids vs those regularly receiving this treatment. Methods: Twenty-two patients (11 corticosteroid free, mean FEV1 99% predicted, 11 corticosteroid-treated, mean FEV1 77% predicted) recruited from our asthma clinic underwent a sputum induction. Sputum was processed according to standard procedure. Eosinophil chemotactic activity contained in the fluid phase was assessed using Boyden microchamber model and expressed as chemotaxis index (CI). Cysteinyl-leukotrienes were measured in sputum supernatant by ELISA and their role in sputum eosionophil chemotactic activity was evaluated by using montelukast, a selective antagonist of a cys-LT1 receptor. Results: Cysteinyl-leukotrienes were well detectable in sputum supernatants from both steroid-naive (247 +/- 42 pg/ml) and steroid-treated (228 +/- 26 pg/ml) asthmatics. Sputum eosinophil chemotactic activity was indiscriminately present in both corticosteroid-naive (CI: 2.61 +/- 0.22) and corticosteroid-treated (2.98 +/- 0.35) asthmatics. Montelukast (100 mu M) significantly inhibited the eosinophil chemotactic activity in both groups achieving a mean inhibition of 54.2 +/- 9.2% (P < 0.001) and 64.7 +/- 7.8% (P < 0.001) in steroid-naive and steroid-treated asthmatics respectively. Conclusion: Cysteinyl-leukotrienes actively participate in sputum eosinophil chemotactic activity found in asthmatics irrespective of whether they are or not under treatment with inhaled corticoids.
Disciplines :
Immunology & infectious disease
Author, co-author :
Hemelaers, L.; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Henket, Monique ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Sele, Jocelyne ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Bureau, Fabrice ; Université de Liège - ULiège > Département de sciences fonctionnelles > Biochimie et biologie moléculaire
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Language :
English
Title :
Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Bousquet J Chanez P Lacoste JY Barneon G Ghavanian N Enander I et al. Eosinophilic inflammation in asthma N Engl J Med 1990 323 1033 1039
Yoo Y Koh YY Kang H Yu J Nah KM Kim CK. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine Allergy 2004 59 1055 1062
Louis R Sele J Henket M Cataldo D Bettiol J Seiden L et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness Allergy 2002 57 907 912
Leckie MJ ten Brinke A Khan J Diamant Z O'Connor BJ Walls CM et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 2000 356 2144 2148
Louis R Lau LC Bron AO Roldaan AC Radermecker M Djukanovic R. The relationship between airways inflammation and asthma severity Am J Respir Crit Care Med 2000 161 9 16
Romagnoli M Vachier I Tarodo dlF Meziane H Chavis C Bousquet J et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics Eur Respir J 2002 20 1370 1377
Green RH Brightling CE McKenna S Hargadon B Parker D Bradding P et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 2002 360 1715 1721
Venge P. Monitoring the allergic inflammation Allergy 2004 59 26 32
Louis R Shute J Biagi S Stanciu L Marrelli F Tenor H et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum Am J Respir Crit Care Med 1997 155 466 472
Spada CS Nieves AL Krauss AH Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro J Leukoc Biol 1994 55 183 191
Laitinen LA Laitinen A Haahtela T Vilkka V Spur BW Lee TH. Leukotriene E4 and granulocytic infiltration into asthmatic airways Lancet 1993 341 989 990
Pavord ID Ward R Woltmann G Wardlaw AJ Sheller JR Dworski R. Induced sputum eicosanoid concentrations in asthma Am J Respir Crit Care Med 1999 160 1905 1909
Hatzelmann A Tenor H Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions Br J Pharmacol 1995 114 821 831
Brightling CE Ward R Woltmann G Bradding P Sheller JR Dworski R et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma Am J Respir Crit Care Med 2000 162 878 882
Spanevello A Beghe B Bianchi A Migliori GB Ambrosetti M Neri M et al. Comparison of two methods of processing induced sputum: selected versus entire sputum Am J Respir Crit Care Med 1998 157 665 668
Dworski R Fitzgerald GA Oates JA Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma Am J Respir Crit Care Med 1994 149 953 959
Dent G Hadjicharalambous C Yoshikawa T Handy RL Powell J Anderson IK et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum Am J Respir Crit Care Med 2004 169 1110 1117
Luijk B Lindemans CA Kanters D van der Heijde R Bertics P Lammers JW et al. Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge J Allergy Clin Immunol 2005 115 997 1003
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.